Abstract
Fresh market spinach has limited herbicides available and weed management in this crop is dependent on hand-weeding. Phenmedipham is a POST herbicide registered for use on spinach grown for processing or for seed, but not fresh market spinach. This study evaluates the potential use of phenmedipham alone and in combination with cycloate for weed control in fresh spinach production. Greenhouse and field studies were conducted in 2013 using two spinach varieties known to have low and high tolerance to phenmedipham. The greenhouse studies showed that phenmedipham at 270 and 550 g ai ha−1 was safe to spinach when applied at the four-leaf stage for the low- and high-tolerance varieties, respectively. Phenmedipham was evaluated alone (550 g ha−1) and applied to the four-leaf stage in two varieties. Subsequently, a second experiment evaluated cycloate (1,700 g ha−1) followed by (fb) phenmedipham at several rates (90, 180, and 270 g ha−1). Phenmedipham alone (550 g ha−1) did not result in crop injury when applied to four-leaf spinach; however, the weed control was not better than cycloate alone. When applied as a sequential treatment following cycloate, all phenmedipham rates were safe to spinach and significantly improved weed control compared to cycloate alone. Cycloate fb phenmedipham at 270 g ha−1 provided 87% weed control relative to cycloate alone. This level of weed control was similar to the cycloate plus hand-weeding treatment, which provided 98% control. Results here show that cycloate fb phenmedipham improves weed control compared to cycloate alone, and has the potential to reduce hand-weeding costs in the fresh spinach production.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.